Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on October 21, 2026
Cost Plus Drugs tests custom rare-disease medicines at its Dallas factory
The shipments were the first test of a plan to change how custom treatments are made and sold.
Today in brief
Cost Plus Drugs’ Dallas factory received shipments of custom medicines for rare diseases, the first test of a plan to change how they are made and sold.1 One shipment contained molecules aimed at a genetic mutation affecting one patient’s neurons. Another was developed to treat a disease that progressively impairs adults’ muscle control.1
Also worth knowing
-
Mark Cuban said the effort could help people with rare diseases. He has spent five years trying to lower the cost of generic medicines.1
Also published
- Pharma’s supplier sprawl problem: When more vendors create less control Pharmaceutical Technology
- Scalable hPSC manufacturing: seamless 2D to 3D cell culture BioTechniques